Toll-like Receptors in Hepatic Ischemia/reperfusion and Transplantation

Overview

Journal Gastroenterol Res Pract

Publisher Wiley

Specialty Gastroenterology

Date 2010 Sep 3

PMID 20811615

Citations 20

Authors

John Evankovich

Timothy Billiar

Allan Tsung

Affiliations

Soon will be listed here.

Abstract

The family of Toll-like receptors (TLRs) function as pattern-recognition receptors (PRRs) that respond to a myriad of highly conserved ligands. These substrates include pathogen-associated molecular patterns (PAMPs) for the recognition of invading pathogens, as well as damage-associated molecular patterns (DAMPs) for the recognition of endogenous tissue injury. While the functions of TLRs are diverse, they have received much attention for their roles in ischemia/reperfusion (I/R) injury of the liver and other organs. The TLRs play central roles in sensing tissue damage and activating the innate immune system following I/R. Engagement of TLRs by endogenous DAMPs activates proinflammatory signaling pathways leading to the production of cytokines, chemokines and further release of endogenous danger signals. This paper focuses on the most recent findings regarding TLR family members in hepatic I/R injury and transplantation.

Citing Articles

Thymoquinone-loaded self-nano-emulsifying drug delivery system against ischemia/reperfusion injury.

Bahloul B, Chaabani R, Zahra Y, Kalboussi N, Kraiem J, Sfar S Drug Deliv Transl Res. 2023; 14(1):223-235.

PMID: 37523093 DOI: 10.1007/s13346-023-01395-8.

Role of Immuno-Inflammatory Signals in Liver Ischemia-Reperfusion Injury.

Kaltenmeier C, Wang R, Popp B, Geller D, Tohme S, Yazdani H Cells. 2022; 11(14).

PMID: 35883665 PMC: 9323912. DOI: 10.3390/cells11142222.

Interleukin-27 in liver xenotransplantation: A rational target to mitigate ischemia reperfusion injury and increase xenograft survival.

Matheson R, Deng K, Huai G, Lee K, Feeney N, Coe T Transplant Rev (Orlando). 2021; 36(1):100674.

PMID: 34861509 PMC: 10072133. DOI: 10.1016/j.trre.2021.100674.

Synergistic effect of the TLR5 agonist CBLB502 and its downstream effector IL-22 against liver injury.

Melin N, Sanchez-Taltavull D, Fahrner R, Keogh A, Dosch M, Buchi I Cell Death Dis. 2021; 12(4):366.

PMID: 33824326 PMC: 8024273. DOI: 10.1038/s41419-021-03654-3.

Trial Watch: Toll-like receptor agonists in cancer immunotherapy.

Smith M, Garcia-Martinez E, Pitter M, Fucikova J, Spisek R, Zitvogel L Oncoimmunology. 2018; 7(12):e1526250.

PMID: 30524908 PMC: 6279325. DOI: 10.1080/2162402X.2018.1526250.

References

Gill R, Tsung A, Billiar T . Linking oxidative stress to inflammation: Toll-like receptors. Free Radic Biol Med. 2010; 48(9):1121-32. PMC: 3423196. DOI: 10.1016/j.freeradbiomed.2010.01.006. View

Shen X, Ke B, Zhai Y, Gao F, Tsuchihashi S, Lassman C . Absence of toll-like receptor 4 (TLR4) signaling in the donor organ reduces ischemia and reperfusion injury in a murine liver transplantation model. Liver Transpl. 2007; 13(10):1435-43. DOI: 10.1002/lt.21251. View

Zwacka R, Zhang Y, Halldorson J, Schlossberg H, Dudus L, Engelhardt J . CD4(+) T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver. J Clin Invest. 1997; 100(2):279-89. PMC: 508190. DOI: 10.1172/JCI119533. View

Yasuda K, Rutz M, Schlatter B, Metzger J, Luppa P, Schmitz F . CpG motif-independent activation of TLR9 upon endosomal translocation of "natural" phosphodiester DNA. Eur J Immunol. 2006; 36(2):431-6. DOI: 10.1002/eji.200535210. View

Caldwell-Kenkel J, Currin R, Tanaka Y, Thurman R, Lemasters J . Kupffer cell activation and endothelial cell damage after storage of rat livers: effects of reperfusion. Hepatology. 1991; 13(1):83-95. View

Hui W, Jinxiang Z, Heshui W, Zhuoya L, Qichang Z . Bone marrow and non-bone marrow TLR4 regulates hepatic ischemia/reperfusion injury. Biochem Biophys Res Commun. 2009; 389(2):328-32. DOI: 10.1016/j.bbrc.2009.08.149. View

Tsung A, Klune J, Zhang X, Jeyabalan G, Cao Z, Peng X . HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling. J Exp Med. 2007; 204(12):2913-23. PMC: 2118528. DOI: 10.1084/jem.20070247. View

Wu H, Zhang J, Wang L, Tian Y, Wang H, Rotstein O . Toll-like receptor 4 involvement in hepatic ischemia/reperfusion injury in mice. Hepatobiliary Pancreat Dis Int. 2004; 3(2):250-3. View

Caldwell-Kenkel J, Currin R, Tanaka Y, Thurman R, Lemasters J . Reperfusion injury to endothelial cells following cold ischemic storage of rat livers. Hepatology. 1989; 10(3):292-9. DOI: 10.1002/hep.1840100307. View

10.

Liu S, Gallo D, Green A, Williams D, Gong X, Shapiro R . Role of toll-like receptors in changes in gene expression and NF-kappa B activation in mouse hepatocytes stimulated with lipopolysaccharide. Infect Immun. 2002; 70(7):3433-42. PMC: 128073. DOI: 10.1128/IAI.70.7.3433-3442.2002. View

11.

Ziegler G, Harhausen D, Schepers C, Hoffmann O, Rohr C, Prinz V . TLR2 has a detrimental role in mouse transient focal cerebral ischemia. Biochem Biophys Res Commun. 2007; 359(3):574-9. DOI: 10.1016/j.bbrc.2007.05.157. View

12.

Leemans J, Stokman G, Claessen N, Rouschop K, Teske G, Kirschning C . Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J Clin Invest. 2005; 115(10):2894-903. PMC: 1201659. DOI: 10.1172/JCI22832. View

13.

Shen X, Ke B, Zhai Y, Gao F, Busuttil R, Cheng G . Toll-like receptor and heme oxygenase-1 signaling in hepatic ischemia/reperfusion injury. Am J Transplant. 2005; 5(8):1793-800. DOI: 10.1111/j.1600-6143.2005.00932.x. View

14.

Yasuda K, Yu P, Kirschning C, Schlatter B, Schmitz F, Heit A . Endosomal translocation of vertebrate DNA activates dendritic cells via TLR9-dependent and -independent pathways. J Immunol. 2005; 174(10):6129-36. DOI: 10.4049/jimmunol.174.10.6129. View

15.

Tsoulfas G, Takahashi Y, Ganster R, Yagnik G, Guo Z, Fung J . Activation of the lipopolysaccharide signaling pathway in hepatic transplantation preservation injury. Transplantation. 2002; 74(1):7-13. DOI: 10.1097/00007890-200207150-00003. View

16.

Beutler B . Inferences, questions and possibilities in Toll-like receptor signalling. Nature. 2004; 430(6996):257-63. DOI: 10.1038/nature02761. View

17.

Seki E, Brenner D . Toll-like receptors and adaptor molecules in liver disease: update. Hepatology. 2008; 48(1):322-35. DOI: 10.1002/hep.22306. View

18.

Knolle P, Schlaak J, Uhrig A, Kempf P, Meyer zum Buschenfelde K, Gerken G . Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge. J Hepatol. 1995; 22(2):226-9. DOI: 10.1016/0168-8278(95)80433-1. View

19.

Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H . A Toll-like receptor recognizes bacterial DNA. Nature. 2000; 408(6813):740-5. DOI: 10.1038/35047123. View

20.

Zhai Y, Qiao B, Gao F, Shen X, Vardanian A, Busuttil R . Type I, but not type II, interferon is critical in liver injury induced after ischemia and reperfusion. Hepatology. 2007; 47(1):199-206. DOI: 10.1002/hep.21970. View